Docket Nexus — Federal court records.
Company · Pharmaceuticals & Biotechnology

Alnylam Pharmaceuticals, Inc

Federal civil lawsuits naming Alnylam Pharmaceuticals, Inc, a Pharmaceuticals & Biotechnology company.

Public CompanyPharmaceuticals & Biotechnology
Ticker
Nasdaq: ALNY
Business
Pharmaceutical Preparations
Headquarters
Cambridge, MA
SEC CIK
1178670

Alnylam Pharmaceuticals, Inc is a public company in Pharmaceutical Preparations, based in Cambridge, MA (traded on Nasdaq as ALNY). It appears in 12 federal civil lawsuits in this index, most often as a plaintiff (7 of 12). These cases are most often Patent and Antitrust matters, filed between 2017 and 2025, most frequently in District Court, D. Delaware. The most common causes of action are Patent Infringement and Antitrust. Frequent opposing parties include Pfizer, Inc, Moderna, Inc, and The Board of Regents of the University of Texas System.

12
Lawsuits
5
As Defendant
7
As Plaintiff
1
Open
11
Terminated
2017–2025
Span
14 mo
Median Duration
1.3 cases/yrPredominantly plaintiff · 58%Patent-heavy · 83%Activity steady

Cases by State

AL — 0 casesAZ — 0 casesAR — 0 casesCA — 0 casesCO — 0 casesCT — 0 casesDE — 7 casesDC — 0 casesFL — 0 casesGA — 0 casesID — 0 casesIL — 0 casesIN — 0 casesIA — 0 casesKS — 0 casesKY — 0 casesLA — 0 casesME — 0 casesMD — 0 casesMA — 3 casesMI — 0 casesMN — 0 casesMS — 0 casesMO — 0 casesMT — 0 casesNE — 0 casesNV — 0 casesNH — 0 casesNJ — 0 casesNM — 0 casesNY — 1 casesNC — 0 casesND — 0 casesOH — 0 casesOK — 0 casesOR — 0 casesPA — 0 casesRI — 0 casesSC — 0 casesSD — 0 casesTN — 0 casesTX — 1 casesUT — 0 casesVT — 0 casesVA — 0 casesWA — 0 casesWV — 0 casesWI — 0 casesWY — 0 cases

Open Cases Over Time

2017peak 5 open2025

Case Types Over Time

20172025
PatentAntitrustSecurities / Commodities

Filings by Year

20172025

Case Types filter →

Patent10
Antitrust1
Securities / Commodities1

Where Filed filter →

Frequent Opposing Parties

Filtered Patent Clear

10 Cases — Newest First